Remdesivir: New Hope Against Corona Virus

Last May, The united states of America allowed the beginning of clinical trials emergency use of an experimental drug known as

Rebel COVID-19 ( Click & Cling Post)

Remdesivir is a broad-spectrum Antiviral medication developed by the bio-pharmaceutical company helping Coronavirus patients to recover faster, so according to the Food and Drug Administration (FDA) commissioner, the drug would be provided as I/V injections for patients hospitalized with Covid-19 to alleviate the burdens and overcome the upraising health crisis.

According to Gilead announcements, the results from Phase 3 Trials of Investigation Antiviral

Gilead added Four additional generic manufactures in Egypt & India to their Licensing agreements including EVA Pharma to further supplyRemdesivir.

More About Remdesivir :

Authorized by the US FDA for emergency treatment for COVID-19 hospitalized patients with severe symptoms.
Originally developed to treat
Side effect such as low blood pressure, nausea, vomiting, sweating, and shivering are associated with Remdesivir in some cases.
Infusion-related reactions & liver transaminase elevations have been observed.
Remdesivir is an investigational drug, and there is no prescribing information. However, the FDA has authorized its distribution with Fact Sheets for both HCPs & Patients as well as Caregivers.